|
About Diabetes
|
Landmark Studies on
Diabetic Amputation Prevention Podiatrists publish two landmark papers in Lancet on World Diabetes Day. The studies, which focus on negative pressure wound therapy and powerful antibiotics for the treatment of infections in the diabetic foot, offer new data and real hope in the battle against amputation. Every 30 seconds a lower limb is lost to diabetes. This is the backdrop for two major studies reported in the November 12, 2005, issue of Lancet by Rosalind Franklin University of Medicine and Sciences’ Center for Lower Extremity Ambulatory Research (CLEAR). Dr. David G. Armstrong, CLEAR’s Director and a principal investigator on both studies, reiterated: “We have just commemorated World Diabetes Day -- and the focus this year was amputation prevention. So, it’s rather timely that these studies come into view now.” The two studies focus on various aspects of diabetic foot care. The first
study evaluates a novel new wound healing technology known as Negative Pressure
Wound Therapy, also known as “VAC” therapy. “This is an important tool in the
battle against amputations,” noted Armstrong, who is Professor of Surgery, Chair
of Research and Assistant Dean at Rosalind Franklin University’s Scholl College
of Podiatric Medicine. “The results of this study suggest strongly that this
technology can take very complex wounds and greatly simplify them. This is the
first large-scale study to lend support to this mechanism of therapy.” Source: Diabetes In Control |